Pubblicazioni dal 2000


35) Carboni E, Carta AR, Carboni E. Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19? Med Hypotheses. 2020 Apr 22;140:109776. doi: 10.1016/j.mehy.2020.109776. Epub ahead of print. PMID: 32344313; PMCID: PMC7175844.

34) Carta AR, Boi L, Pisanu A, Palmas MF, Carboni E,De Simone A. Advances in modelling alpha-synuclein-induced Parkinson’s diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species. J Neurosci Methods.2020 May 15;338:108685. doi: 10.1016/j.jneumeth.2020.108685. Epub 2020 Mar 12. PMID: 32173400.

33) Jadzic D, Bassareo V, Carta AR, Carboni E. Nicotine, cocaine, amphetamine, morphine, and ethanol increase norepinephrine output in the bed nucleus of stria terminalis of freely moving rats. Addict Biol. 2019 Dec 17:e12864. doi: 10.1111/adb.12864. Epub ahead of print. PMID: 31849152.

32) Zoratto F, Palombelli GM, Ruocco LA, Carboni E,Laviola G, Sadile AG, Adriani W, Canese R. Enhanced limbic/impaired cortical-loop connection onto the hippocampus of NHE rats: Application of resting-state functional connectivity in a preclinical ADHD model. Behav Brain Res.2017 Aug 30;333:171-178. doi: 10.1016/j.bbr.2017.06.026. Epub 2017 Jun 26. PMID: 28655564.

31) Mulas G, Espa E, Fenu S, Spiga S, Cossu G, Pillai E, Carboni E,Simbula G, Jadžić D, Angius F, Spolitu S, Batetta B, Lecca D, Giuffrida A, Carta AR. Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson’s disease. Exp Neurol. 2016 Dec;286:83-92. doi: 10.1016/j.expneurol.2016.09.013. Epub 2016 Sep 30. PMID: 27697481.

30)Cadeddu R, Jadzic D, Carboni E. Ketamine modulates catecholamine transmission in the bed nucleus of stria terminalis: The possible role of this region in the  antidepressant effects of ketamine. Eur Neuropsychopharmacol.2016  Oct;26(10):1678-82. doi: 10.1016/j.euroneuro.2016.08.009. Epub 2016 Aug 25. PMID: 27569123.

29) Ruocco LA, Treno C, Gironi Carnevale UA, Arra C, Boatto G, Pagano C, Tino A, Nieddu M, Michel M, Prikulis I,Carboni E,de Souza Silva MA, Huston JP, Sadile AG, Korth C. Immunization with DISC1 protein in an animal model of ADHD influences behavior and excitatory amino acids in prefrontal cortex and striatum. Amino Acids.2015Mar;47(3):637-50. doi: 10.1007/s00726-014-1897-6. Epub 2015 Jan 17. PubMed PMID: 25595600.

28) Melis M, Carboni E,Caboni P, Acquas E. Key role of salsolinol in ethanol actions on dopamine neuronal activity of the posterior ventral tegmental area. Addict Biol. 2015Jan;20(1):182-93. doi: 10.1111/adb.12097. Epub 2013 Sep 17. PubMed PMID: 24103023.

27) Rosas M, Zaru A, Sabariego M, Giugliano V, Carboni E,Colombo G, Acquas E. Differential sensitivity of ethanol-elicited ERK phosphorylation in nucleus accumbens of Sardinian alcohol-preferring and -non preferring rats. Alcohol.2014 Aug;48(5):471-6. doi: 10.1016/j.alcohol.2014.04.002. Epub 2014 May 14. PubMed PMID: 24877898.

26) Ruocco LA, Treno C, Gironi Carnevale UA, Arra C, Boatto G, Nieddu M, Pagano C, Illiano P, Barbato F, Tino A,Carboni E,Laviola G, Lacivita E, Leopoldo M, Adriani W, Sadile AG. Prepuberal stimulation of 5-HT7-R by LP-211 in a rat model  of hyper-activity and attention-deficit: permanent effects on attention, brain amino acids and synaptic markers in the fronto-striatal interface. PLoS One.2014 Apr 7;9(4):e83003. doi: 10.1371/journal.pone.0083003. eCollection 2014. PubMed PMID: 24709857; PubMed Central PMCID: PMC3977819.

25) Cadeddu R, Ibba M, Sadile A, Carboni E. Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible  role in antidepressant therapy? Psychopharmacology (Berl)2014 May;231(9):1925-33. doi: 10.1007/s00213-013-3335-y. Epub 2013 Nov 13. PubMed PMID: 24221827.

24) Carta AR, Carboni E,Spiga S. The MPTP/probenecid model of progressive Parkinson’s disease.Methods Mol Biol.2013;964:295-308. doi: 10.1007/978-1-62703-251-3_17. PubMed PMID: 23296790.

23)  Carboni E,Cadeddu R, Carta AR .     Role of Prefrontal Cortex Dopamine and Noradrenaline Circuitry in Addiction. In: Belin D. Addiction . RIJEKA: InTech Web Org, 2012.ISBN: 979-953-307-092-5

22)Carta AR, Frau L, Pisanu A, Wardas J, Spiga S, Carboni E. Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson’s disease model. Neuroscience.2011Oct 27;194:250-61. Epub 2011 Jul 27. PubMed PMID: 21839812.

21)Carta AR, Pisanu A, Carboni E. Do PPAR-Gamma Agonists Have a Future in Parkinson’s Disease Therapy? Parkinsons Dis2011;2011:689181. Epub 2011 Mar 29. PubMed PMID: 21603186; PubMed Central PMCID: PMC3096077.

20)Ruocco LA, Carnevale UA, Treno C, Sadile AG, Melisi D, Arra C, Ibba M, Schirru C andCarboni E.(2010). Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples High-Excitability rats. Behavioral Brain Research.Vol 210(1) pp 99-106. (Feb 12. 2010).

19): Fumagalli F, Cattaneo A, Caffino L, Ibba M, Racagni G, Carboni E, Gennarelli M, Riva MA. Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. Pharmacol Res. 2010Dec;62(6):523-9. doi:10.1016/j.phrs.2010.07.009. Epub 2010 Aug 5. PubMed PMID: 20691787.

18) Carboni E, Barros VG, Ibba M, Silvagni A, Mura C, Antonelli MC (2010). Prenatal Restraint Stress: An in Vivo Microdialysis Study on Catecholamine Release in the Rat Prefrontal Cortex. Neuroscience 2010.  Vol 168 pp 156-166 ((Mar 27 2010).

17)Schintu N, Frau L, Ibba M, Garau A, Carboni E,Carta AR. Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson’s Disease. Neurotox Res 2009 Aug;16(2):127-39.

16)Schintu N, Frau L, Ibba M, Caboni P, Garau A,Carboni E,Carta AR (2009). PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson’s disease. Eur J Neurosci. 2009Feb 24.

15) Carboni Ezioand Anna Rosa Carta    The Interrelationship of Dopamine and Noradrenaline in the Prefrontal Cortex : from Physioolgy to Therapy. In: Prefrontal Cortex: Roles, Intervention and Traumas.LoGrasso Lorenzo Morretti Giovanni Eds. Nova Science Publishers Hauppauge NY. 2009

14)Silvagni A, Barros VG, Mura C, Antonelli MC,Carboni E.(2008).Prenatal restraint stress differentially modifies basal and stimulated dopamine and noradrenaline release in the nucleus accumbens shell: an ‘in vivo’ microdialysis study in adolescent and young adult rats. Eur J Neurosci.2008Aug;28(4):744-58.

13)Ruocco LA, Viggiano D, Viggiano A, Abignente E, Rimoli MG, Melisi D, Curcio A, Nieddu M, Boatto G, Carboni E,Carnevale UA, Sadile AG. (2008)Galactosylated dopamine enters into the brain, blocks the mesocorticolimbic system and modulates activity and scanning time in Naples high excitability rats.Neuroscience.2008 Mar 3;152(1):234-44.

12) Ruocco LA, Viggiano D, Pignatelli M, Iannaccone T, Rimoli MG, Melisi D, Curcio A, De Lucia S,Carboni E,Carnevale UA, de Caprariis P, Sadile AG. (2008). Galactosilated dopamine increases attention without reducing activity in C57BL/6 mice. Behav Brain Res.2008Mar 5;187(2):449-54. Epub 2007 Oct 13.

11) Carboni E, Silvagni A, Vacca C, Di Chiara G (2006) Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex J Neurochem. 2006 Jan;96(2):473-81. Epub 2005 Nov 29

10) Carboni E, Silvagni A. (2004) Dopamine reuptake by norepinephrine neurons: exception or rule? Crit Rev Neurobiol.2004;16(1-2):121-8. Review

9)Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, Acquas E, Carboni E,Valentini V, Lecca D. (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology.2004;47 Suppl 1:227-41. Review.

8) Carboni E,Silvagni A. (2004). Experimental investigations on dopamine transmission can provide clues on the mechanism of the therapeutic effect of amphetamine and methylphenidate in ADHD. Neural Plast.2004;11(1-2):77-95. Review.

7) Carboni E,Silvagni A, Valentini V, Di Chiara G. (2003). Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdyalisis study.Neurosci Biobehav Rev.2003 Nov;27(7):653-9.

6) Carboni E, Vacca C. (2003). Conditioned place preference. A simple method for investigating reinforcing properties in laboratory animals. Methods Mol Med. 2003;79:481-98.

5) Carboni E. (2003) Microdialysis coupled with electrochemical detection. A way to investigate brain monoamine role in freely moving animals. Methods Mol Med.79:415-32.

4) Carboni E,Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G. (2001). Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci.2001 May 1;21(9):RC141: 1-4.

3) Carboni E, Silvagni A, Rolando MT, Di Chiara G. (2000) Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J Neurosci.2000 Oct 15;20(20):RC102.

2) Carboni E, Bortone L, Giua C, Di Chiara G. (2000). Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats.Drug Alcohol Depend.2000 Feb 1;58(1-2):93-102.

1) Carboni E,Rolando MT, Silvagni A, Di Chiara G. (2000) Increase of dialysate dopamine in the bed nucleus of stria terminalis by clozapine and related neuroleptics.Neuropsychopharmacology.2000 Feb;22(2):140-7


CAPITOLI IN LIBRI di atti di congressi  DAL 2000

1) Carboni E., Vacca C., Giros B., and Di Chiara ROLE OF DOPAMINE AND NOREPINEPHRINE TRANSPORTER IN THE EFFECT OF COCAINE: A MICRODIALYSIS STUDY. In Monitoring Molecules in Neuroscience. O’Connor W., Lowry P.J., O’Connor J.J. O’Neill R.D. Eds. University College of Dublin. Dublin 2001.

2)  E. Carboni, A. Silvagni, V. Valentini and G. Di Chiara:      A MICRODIALYSIS STUDY OF DOPAMINE TRANSMISSION IN THE NUCLEUS ACCUMBENS SHELL OF SHR RATS: A MODEL OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD). In Monitoring Molecules in Neuroscience Kehr J., Fuxe K., Ungersted U. Svensson T. Eds. Karolinska University Press, Stockholm, Sweden, pp. 76-78, 2003.

 3) A. Silvagni, E. Carboni, C. Vacca and G. Di Chiara:      EFFECT OF DOPAMINE AND NOREPINEPHRINE CARRIER BLOCKADE ON EXTRACELLULAR DOPAMINE RELEASE IN RAT BRAIN. In Monitoring Molecules in Neuroscience Kehr J., Fuxe K., Ungersted U. Svensson T. Eds. Karolinska University Press, Stockholm, Sweden, pp. 374-376, 2003.

4)  Silvagni A, Barros G, Di Chiara G, Carboni E      A challenge dose of amphetamine can be used as a tool for assessing changes in dopamine and noradrenaline transmission induced by prenatal stress in rats. In. Monitoring Molecules in Neuroscience 2006, Di Chiara G, Carboni E, Valentini V, Acquas E, Bassareo V, Cadoni C, Eds. University of Cagliari, Cagliari Press.

5)  Ibba M, Carboni E.        Effects of sub-chronic methylphenidate and atomoxetine on noradrenaline and dopamine transmission in the prefrontal cortex of adolescent SH rats, an animal model of ADHD. In: Westerink B, Clinckers R, Smolders I, Sarre S, Michotte Y.. (a cura di): Westerink B, Clinckers R, Smolders I, Sarre S, Michotte Y., Proceedings of the 13th International Conference on In Vivo Methods. Monitoring Molecules in Neuroscience vol. 13, p. 108-110, BRUSSEL:Vrije Universiteit, ISBN: 978-90-9025672-6, BRUSSEL, 12-16 september 2010

 6)  Ibba M, Simola N, Cosseddu S, Carboni E.,        GENDER SPECIFIC REDUCTION OF HYPERMOTILITY BY SUB-CHRONIC METHYLPHENIDATE OR ATOMOXETINE IN SH RATS, AN ANIMAL MODEL OF ADHD. In: In: Westerink B, Clinckers R, Smolders I, Sarre S, Michotte Y.. (a cura di): Westerink B, Clinckers R, Smolders I, Sarre S, Michotte Y., Proceedings of the 13th International Conference on In Vivo Methods. Monitoring Molecules in Neuroscience vol. 13, pp. 498-500, BRUSSEL:Vrije Universiteit, ISBN: 978-90-9025672-6, BRUSSEL, 12-16 september 2010






























credits | accessibilità Università degli Studi di Cagliari
C.F.: 80019600925 - P.I.: 00443370929
note legali | privacy

Nascondi la toolbar